+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Polymerase Chain Reaction Market Size, Share & Trends Analysis Report by Type (Conventional PCR), by Product (Instruments, Consumables & Reagents, Software & Services), by Application, by Region, and Segment Forecasts, 2022-2030

  • PDF Icon

    Report

  • 170 Pages
  • July 2022
  • Region: Global
  • Grand View Research
  • ID: 5440511
Description Jump to:
The global polymerase chain reaction market size is expected to reach USD 18.44 billion by 2030. It is expected to expand at a CAGR of 7.5% from 2022 to 2030. The demand for polymerase chain reaction (PCR) testing is expected to be driven by the increasing demand for advanced diagnostic techniques; rising forensic and research applications; and the growing prevalence of diseases such as chronic diseases, infectious diseases, and genetic disorders. Moreover, increasing demand for genetic testing procedures and the introduction of novel technologies are other key factors likely to increase the demand for PCR testing.

The market is expected to witness growth opportunities owing to factors such as the increasing adoption of advanced diagnostic tests and the growing adoption of PCR technologies in medical and non-medical applications. Moreover, the launch of novel technologies, an increasing number of CROs, and research and forensic laboratories are expected to propel the demand forward during the forecast period. Several research institutes and CROs are involved in genomics-based research to develop innovative strategies for disease management.

The introduction of novel and technologically advanced tests is opening new growth opportunities. For instance, in January 2021, GeneIQ announced the launch of its 4-in-1 PCR test for the detection of influenza B (Flu B), influenza A (Flu A), respiratory syncytial virus (RSV), and SARS-CoV-2. Similarly, in December 2020, Menarini Diagnostics launched a molecular test that is used to distinguish between Flu and SARS-CoV-2. Such initiatives will increase the demand for novel PCR tests.

Favorable initiatives undertaken by government bodies are encouraging the players to develop novel molecular tests for different applications. For instance, in January 2020, the University of Helsinki in collaboration with the European Union under the EU/EFPIA Innovative Medicines Initiative Joint Undertaking, funded research for the assessment of qPCR for microbiota profiling. In the study, the iCycler iQ thermal cycler system was used with HOT FIREPol EvaGreen qPCR Mix Plus for studying Clostridium cluster XIVa. Moreover, in March 2020, International Atomic Energy Agency (IAEA) announced a partnership with the Food and Agriculture Organization of the United Nations (FAO) for supporting the use of reverse transcription-PCR.

Several companies are adopting strategies such as acquisitions for strengthening their positions. Acquisition assists companies to enhance their offerings, capabilities, and competencies. For instance, in January 2021, Thermo Fisher Scientific, Inc. announced that it has acquired Mesa Biotech, Inc. - a molecular diagnostic company for USD 450 million to strengthen its product portfolio. Thus, various strategies adopted by companies are anticipated to propel the demand forward over the forecast period.

Polymerase Chain Reaction Market Report Highlights

  • In 2021, the medical application segment dominated the market owing to the rising application of PCR in clinical diagnostics and drug development and research
  • The consumables and reagents product segment held the largest revenue share in 2021 and is expected to retain its dominance over the forecast period
  • North America dominated the market in 2021 due to the presence of favorable regulations and various initiatives about the advancements in healthcare infrastructure undertaken by the government and the high prevalence of diseases in the region

Table of Contents

Chapter 1 Methodology and Scope
1.1 Market Segmentation
1.1.1 Segment Scope
1.1.2 Regional Scope
1.1.3 Estimates And Forecast Timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased Database
1.3.2 Internal Database
1.3.3 Secondary Sources
1.3.4 Primary Research
1.3.5 Details Of Primary Research
1.4 Information or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis
1.6.1.1 Approach 1: Commodity flow approach
1.6.1.2 Approach 2: Country-wise market estimation using bottom-up approach
1.6.1.3 Approach 3: Country-wise market estimation using top-down approach
1.7 Global Market: CAGR Calculation
1.8 Research Assumptions
1.9 Key KoL Responses
1.10 Market Share Calculations
1.11 List of Secondary Sources
1.12 Objectives
1.12.1 Objective 1:
1.12.2 Objective 2:
1.13 List of Abbreviations
Chapter 2 Executive Summary
2.1 Market Summary
Chapter 3 PCR Market - Industry Outlook
3.1 Market Lineage Outlook
3.1.1 Parent Market Lineage Outlook
3.1.2 Related/Ancillary Market Outlook
3.2 Penetration & Growth Prospect Mapping
3.3 Market Dynamics
3.3.1 Market Drivers
3.3.1.1 Rising incidence of chronic diseases, infectious diseases, and genetic disorders
3.3.1.2 Technological advancements in PCR
3.3.1.3 Implementation of MIQE guidelines
3.3.1.4 Increasing demand for rapid diagnostic tests and growing adoption of PCR technologies
3.3.1.5 Increasing number of CROs and forensic & research laboratories
3.3.1.6 Increasing demand for prenatal genetic testing procedures
3.3.1.7 Outbreak of COVID-19
3.3.2 Market Restraint Analysis
3.3.2.1 High qPCR device costs
3.3.2.2 Stringent regulatory policies
3.4 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
3.5 Industry Analysis - Porter’s
3.6 Reimbursement & Regulatory Scenario
3.7 Major Deals & Strategic Alliances
3.7.1 New Product Launch
3.7.2 Acquisition
3.7.3 Expansion
3.7.4 Partnerships
3.7.5 Marketing & Promotions
3.7.5.1 Market entry strategies
3.7.6 Unmet Need Analysis
3.7.6.1 Need for rapid diagnosis
3.7.6.2 Affordability
3.7.6.3 Limited scope of pathogen detection
3.7.7 Change In Market Dynamics After The Launch Of Novel PCR Devices
3.7.7.1 Medical
3.7.7.2 Non-Medical
3.7.8 Comparison Of Existing PCR With Plasmonic PCR
3.7.8.1 Potential for COVID-19
3.7.9 Consumer Behavior Analysis
Chapter 4 PCR Market Analysis: Type Scope, 2018 - 2030 (Revenue, USD Million)
4.1 PCR Market: Type Movement Analysis
4.2 Conventional PCR
4.2.1 Conventional PCR Market Estimates And Forecast, 2018 - 2030 (USD Million)
4.3 Others
4.3.1 Others Market Estimates And Forecast, 2018 - 2030 (USD Million)
Chapter 5 PCR Market Analysis: Product Scope, 2018 - 2030 (Revenue, USD Million)
5.1 PCR Market: Product Movement Analysis
5.2 Consumables & Reagents
5.2.1 Consumables & Reagents Market Estimates And Forecast, 2018 - 2030 (USD Million)
5.3 Instruments
5.3.1 Instruments Market Estimates And Forecast, 2018 - 2030 (USD Million)
5.4 Software & Services
5.4.1 Software & Services Market Estimates And Forecast, 2018 - 2030 (USD Million)
Chapter 6 PCR Market Analysis: Application Scope, 2018 - 2030 (Revenue, USD Million)
6.1 PCR Market: Application Movement Analysis
6.2 Medical
6.2.1 Medical Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.2.2 Clinical
6.2.3 Clinical Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.2.3.1 Pathogen Testing
6.2.3.1.1 Pathogen Testing Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.2.3.2 Oncology Testing
6.2.3.2.1 Oncology Testing Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.2.3.3 Blood Screening
6.2.3.3.1 Blood Screening Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.2.3.4 Others
6.2.3.4.1 Others Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.2.4 Research
6.2.4.1 Research Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.2.5 Forensics And Others
6.2.5.1 Forensics and other market estimates and forecast, 2018 - 2030 (USD Million)
6.3 Non-medical
6.3.1 Non-Medical Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.3.2 Food
6.3.2.1 Food Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.3.3 Others
6.3.3.1 Others Market Estimates And Forecast, 2018 - 2030 (USD Million)
Chapter 7 PCR Market Analysis, Regional Scope, 2018 - 2030, (Revenue, USD Million)
7.1 Market Share Analysis by Country, 2021 & 2030
7.1.1 North America
7.1.1.1 North America market estimates and forecast, 2018 - 2030 (USD Million)
7.1.1.2 U.S.
7.1.1.2.1 U.S. market estimates and forecast, 2018 - 2030 (USD Million)
7.1.1.3 Canada
7.1.1.3.1 Canada market estimates and forecast, 2018 - 2030 (USD Million)
7.1.2 Europe
7.1.2.1 Europe market estimates and forecast, 2018 - 2030 (USD Million)
7.1.2.2 U.K.
7.1.2.2.1 U.K. market estimates and forecast, 2018 - 2030 (USD Million)
7.1.2.3 Germany
7.1.2.3.1 Germany market estimates and forecast, 2018 - 2030 (USD Million)
7.1.2.4 France
7.1.2.4.1 France market estimates and forecast, 2018 - 2030 (USD Million)
7.1.2.5 Italy
7.1.2.5.1 Italy market estimates and forecast, 2018 - 2030 (USD Million)
7.1.2.6 Spain
7.1.2.6.1 Spain market estimates and forecast, 2018 - 2030 (USD Million)
7.1.3 Asia Pacific
7.1.3.1 Asia Pacific market estimates and forecast, 2018 - 2030 (USD Million)
7.1.3.2 Japan
7.1.3.2.1 Japan market estimates and forecast, 2018 - 2030 (USD Million)
7.1.3.3 China
7.1.3.3.1 China market estimates and forecast, 2018 - 2030 (USD Million)
7.1.3.4 India
7.1.3.4.1 India market estimates and forecast, 2018 - 2030 (USD Million)
7.1.3.5 South Korea
7.1.3.5.1 South Korea market estimates and forecast, 2018 - 2030 (USD Million)
7.1.3.6 Australia
7.1.3.6.1 Australia market estimates and forecast, 2018 - 2030 (USD Million)
7.1.4 Latin America
7.1.4.1 Latin America market estimates and forecast, 2018 - 2030 (USD Million)
7.1.4.2 Brazil
7.1.4.2.1 Brazil market estimates and forecast, 2018 - 2030 (USD Million)
7.1.4.3 Mexico
7.1.4.3.1 Mexico market estimates and forecast, 2018 - 2030 (USD Million)
7.1.4.4 Argentina
7.1.4.4.1 Argentina market estimates and forecast, 2018 - 2030 (USD Million)
7.1.5 Middle East And Africa
7.1.5.1 Middle East & Africa market estimates and forecast, 2018 - 2030 (USD Million)
7.1.5.2 South Africa
7.1.5.2.1 South Africa market estimates and forecast, 2018 - 2030 (USD Million)
7.1.5.3 Saudi Arabia
7.1.5.3.1 Saudi Arabia market estimates and forecast, 2018 - 2030 (USD Million)
7.1.5.4 UAE
7.1.5.4.1 UAE market estimates and forecast, 2018 - 2030 (USD Million)
Chapter 8 PCR Market: Competitive Analysis
8.1 Recent Developments and Impact Analysis, by Key Market Participants
8.1.1 Ansoff Matrix`
8.2 Company Categorization
8.2.1 Innovators
8.2.1.1 Market Differentiators
8.3 Vendor Landscape
8.3.1 List Of Key Distributors And Channel Partners
8.3.2 Key Customers
8.3.3 Key Company Market Share Analysis, 2021
8.4 Public Companies
8.4.1 Competitive Dashboard Analysis
8.5 Private Companies
8.5.1 List Of Key Emerging Companies
8.6 Regional Network Map
8.7 Key Regional/Local Competitors for PCR Consumables/Enzymes in Japan, Australia, Korea, India, Singapore, and Europe
8.8 Company Profiles
8.8.1 ABBOTT
8.8.1.1 Company overview
8.8.1.2 Financial performance
8.8.1.3 Product benchmarking
8.8.1.4 Strategic initiatives
8.8.2 QIAGEN
8.8.2.1 Company overview
8.8.2.2 Financial performance
8.8.2.3 Product benchmarking
8.8.2.4 Strategic initiatives
8.8.3 BIO-RAD LABORATORIES, INC.
8.8.3.1 Company overview
8.8.3.2 Financial performance
8.8.3.3 Product benchmarking
8.8.3.4 Strategic initiatives
8.8.4 AGILENT TECHNOLOGIES, INC.
8.8.4.1 Company overview
8.8.4.2 Financial performance
8.8.4.3 Product benchmarking
8.8.4.4 Strategic initiatives
8.8.5 THERMO FISHER SCIENTIFIC, INC.
8.8.5.1 Company overview
8.8.5.2 Affymetrix
8.8.5.3 Company overview
8.8.5.4 Financial performance
8.8.5.5 Product benchmarking
8.8.5.6 Strategic initiatives
8.8.6 CYTIVA (GE HEALTHCARE)
8.8.6.1 Company overview
8.8.6.2 Financial performance
8.8.6.3 Product benchmarking
8.8.6.4 Strategic initiatives
8.8.7 BIOMÉRIEUX SA
8.8.7.1 Company overview
8.8.7.2 Financial performance
8.8.7.3 Product benchmarking
8.8.7.4 Strategic initiatives
8.8.8 F. HOFFMANN-LA ROCHE LTD.
8.8.8.1 Company overview
8.8.8.2 Financial performance
8.8.8.3 Product benchmarking
8.8.8.4 Strategic initiatives
8.8.9 FLUIDIGM CORPORATION
8.8.9.1 Company overview
8.8.9.2 Financial performance
8.8.9.3 Product benchmarking
8.8.9.4 Strategic initiatives
8.8.10 STILLA
8.8.10.1 COMPANY OVERVIEW
8.8.10.2 Product benchmarking
8.8.10.3 Strategic initiatives
8.8.11 MICROSYNTH AG
8.8.11.1 Company overview
8.8.11.2 Product benchmarking
8.8.11.3 Strategic initiatives
8.8.12 JN MEDSYS
8.8.12.1 Company overview
8.8.12.2 Product benchmarking
8.8.12.3 Strategic initiatives
8.8.13 DANAHER CORPORATION
8.8.13.1 Company overview
8.8.13.2 Cepheid
8.8.13.3 Beckman Coulter
8.8.13.4 Leica Biosystems
8.8.13.5 Financial performance
8.8.13.6 Product benchmarking
8.8.13.7 Strategic initiatives
List of Tables
Table 1 List of secondary sources
Table 2 List of Abbreviations
Table 3 Incidence of diseases
Table 4 EUA (Emergency Use Authorization) PCR tests for COVID-19
Table 5 EUA (Emergency Use Authorization) molecular diagnostics tests for COVID-19 in 2021
Table 6 Comparison of existing PCR with Plasmonic PCR
Table 7 Real-time RT-PCR kits with EUA for COVID-19
Table 8 PCR systems with EUA for COVID-19
Table 9 North America PCR market, by Country, 2018-2030 (USD Million)
Table 10 North America PCR market, by type, 2018-2030 (USD Million)
Table 11 North America PCR market, by product, 2018-2030 (USD Million)
Table 12 North America PCR market, by application, 2018-2030 (USD Million)
Table 13 U.S. PCR market, by type, 2018-2030 (USD Million)
Table 14 U.S. PCR market, by product, 2018-2030 (USD Million)
Table 15 U.S. PCR market, by application, 2018-2030 (USD Million)
Table 16 Canada PCR market, by type, 2018-2030 (USD Million)
Table 17 Canada PCR market, by product, 2018-2030 (USD Million)
Table 18 Canada PCR market, by application, 2018-2030 (USD Million)
Table 19 Europe PCR market, by Country, 2018-2030 (USD Million)
Table 20 Europe PCR market, by type, 2018-2030 (USD Million)
Table 21 Europe PCR market, by product, 2018-2030 (USD Million)
Table 22 Europe PCR market, by application, 2018-2030 (USD Million)
Table 23 U.K. PCR market, by type, 2018-2030 (USD Million)
Table 24 U.K. PCR market, by product, 2018-2030 (USD Million)
Table 25 U.K. PCR market, by application, 2018-2030 (USD Million)
Table 26 Germany PCR market, by type, 2018-2030 (USD Million)
Table 27 Germany PCR market, by product, 2018-2030 (USD Million)
Table 28 Germany PCR market, by application, 2018-2030 (USD Million)
Table 29 France PCR market, by type, 2018-2030 (USD Million)
Table 30 France PCR market, by product, 2018-2030 (USD Million)
Table 31 France PCR market, by application, 2018-2030 (USD Million)
Table 32 Italy PCR market, by type, 2018-2030 (USD Million)
Table 33 Italy PCR market, by product, 2018-2030 (USD Million)
Table 34 Italy PCR market, by application, 2018-2030 (USD Million)
Table 35 Spain PCR market, by type, 2018-2030 (USD Million)
Table 36 Spain PCR market, by product, 2018-2030 (USD Million)
Table 37 Spain PCR market, by application, 2018-2030 (USD Million)
Table 38 Asia Pacific PCR market, by Country, 2018-2030 (USD Million)
Table 39 Asia Pacific PCR market, by type, 2018-2030 (USD Million)
Table 40 Asia Pacific PCR market, by product, 2018-2030 (USD Million)
Table 41 Asia Pacific PCR market, by application, 2018-2030 (USD Million)
Table 42 Japan PCR market, by type, 2018-2030 (USD Million)
Table 43 Japan PCR market, by product, 2018-2030 (USD Million)
Table 44 Japan PCR market, by application, 2018-2030 (USD Million)
Table 45 China PCR market, by type, 2018-2030 (USD Million)
Table 46 China PCR market, by product, 2018-2030 (USD Million)
Table 47 China PCR market, by application, 2018-2030 (USD Million)
Table 48 India PCR market, by type, 2018-2030 (USD Million)
Table 49 India PCR market, by product, 2018-2030 (USD Million)
Table 50 India PCR market, by application, 2018-2030 (USD Million)
Table 51 Australia PCR market, by type, 2018-2030 (USD Million)
Table 52 Australia PCR market, by product, 2018-2030 (USD Million)
Table 53 Australia PCR market, by application, 2018-2030 (USD Million)
Table 54 South Korea PCR market, by type, 2018-2030 (USD Million)
Table 55 South Korea PCR market, by product, 2018-2030 (USD Million)
Table 56 South Korea PCR market, by application, 2018-2030 (USD Million)
Table 57 Latin America PCR market, by Country, 2018-2030 (USD Million)
Table 58 Latin America PCR market, by type, 2018-2030 (USD Million)
Table 59 Latin America PCR market, by product, 2018-2030 (USD Million)
Table 60 Latin America PCR market, by application, 2018-2030 (USD Million)
Table 61 Brazil PCR market, by type, 2018-2030 (USD Million)
Table 62 Brazil PCR market, by product, 2018-2030 (USD Million)
Table 63 Brazil PCR market, by application, 2018-2030 (USD Million)
Table 64 Mexico PCR market, by type, 2018-2030 (USD Million)
Table 65 Mexico PCR market, by product, 2018-2030 (USD Million)
Table 66 Mexico PCR market, by application, 2018-2030 (USD Million)
Table 67 Argentina PCR market, by type, 2018-2030 (USD Million)
Table 68 Argentina PCR market, by product, 2018-2030 (USD Million)
Table 69 Argentina PCR market, by application, 2018-2030 (USD Million)
Table 70 Middle East & Africa PCR market, by Country, 2018-2030 (USD Million)
Table 71 Middle East & Africa PCR market, by type, 2018-2030 (USD Million)
Table 72 Middle East & Africa PCR market, by product, 2018-2030 (USD Million)
Table 73 Middle East & Africa PCR market, by application, 2018-2030 (USD Million)
Table 74 South Africa PCR market, by type, 2018-2030 (USD Million)
Table 75 South Africa PCR market, by product, 2018-2030 (USD Million)
Table 76 South Africa PCR market, by application, 2018-2030 (USD Million)
Table 77 Saudi Arabia PCR market, by type, 2018-2030 (USD Million)
Table 78 Saudi Arabia PCR market, by product, 2018-2030 (USD Million)
Table 79 Saudi Arabia PCR market, by application, 2018-2030 (USD Million)
Table 80 UAE PCR market, by type, 2018-2030 (USD Million)
Table 81 UAE PCR market, by product, 2018-2030 (USD Million)
Table 82 UAE PCR market, by application, 2018-2030 (USD Million)
List of Figures
Fig. 1 PCR market segmentation
Fig. 2 Market research process
Fig. 3 Data triangulation techniques
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value-chain-based sizing & forecasting
Fig. 7 QFD modeling for market share assessment
Fig. 8 Market formulation & validation
Fig. 9 PCR market snapshot
Fig. 10 Parent market outlook
Fig. 11 Related/ancillary market outlook, revenue, 2021, USD Billion
Fig. 12 Penetration and growth prospect mapping
Fig. 13 PCR market driver impact
Fig. 14 PCR market restraint impact
Fig. 15 SWOT analysis, by a factor (Political & legal, economic, and technological)
Fig. 16 Industry Analysis-Porter’s
Fig. 17 Strategy mapping
Fig. 18 PCR market - Unmet needs analysis
Fig. 19 Consumer behavior analysis
Fig. 20 PCR market: Type outlook and key takeaways
Fig. 21 PCR market: Type movement analysis & market share 2021 & 2030
Fig. 22 Conventional PCR market estimates and forecast, 2018-2030(USD Million)
Fig. 23 Others market estimates and forecast, 2018-2030(USD Million)
Fig. 24 PCR market: Product outlook and key takeaways
Fig. 25 PCR market: Product movement analysis & market share 2021 & 2030
Fig. 26 Consumables & reagents market estimates and forecast, 2018-2030 (USD Million)
Fig. 27 Instruments market estimates and forecast, 2018-2030 (USD Million)
Fig. 28 Software & services market estimates and forecast, 2018-2030 (USD Million)
Fig. 29 PCR market: Application outlook and key takeaways
Fig. 30 PCR market: Application movement analysis & market share 2021 & 2030
Fig. 31 Medical market estimates and forecast, 2018-2030 (USD Million)
Fig. 32 Clinical market estimates and forecast, 2018-2030 (USD Million)
Fig. 33 Pathogen testing market estimates and forecast, 2018-2030 (USD Million)
Fig. 34 Oncology testing market estimates and forecast, 2018-2030 (USD Million)
Fig. 35 Blood screening market estimates and forecast, 2018-2030 (USD million)
Fig. 36 Others market estimates and forecast, 2018-2030 (USD Million)
Fig. 37 Research market estimates and forecast, 2018-2030 (USD Million)
Fig. 38 Forensics and others market estimates and forecast, 2018-2030 (USD Million)
Fig. 39 Non-medical market estimates and forecast, 2018-2030 (USD Million)
Fig. 40 Food market estimates and forecast, 2018-2030 (USD Million)
Fig. 41 Others market estimates and forecast, 2018-2030 (USD Million)
Fig. 42 PCR market: Regional outlook and key takeaways
Fig. 43 Regional outlook, 2021 & 2030
Fig. 44 North America
Fig. 45 North America. market estimates and forecast, 2018-2030 (USD Million)
Fig. 46 U.S.
Fig. 47 U.S. market estimates and forecast, 2018-2030 (USD Million)
Fig. 48 Canada
Fig. 49 Canada market estimates and forecast, 2018-2030 (USD Million)
Fig. 50 Europe
Fig. 51 Europe market estimates and forecast, 2018-2030 (USD Million)
Fig. 52 U.K.
Fig. 53 U.K. market estimates and forecast, 2018-2030 (USD Million)
Fig. 54 Germany
Fig. 55 Germany market estimates and forecast, 2018-2030 (USD Million)
Fig. 56 France
Fig. 57 France market estimates and forecast, 2018-2030 (USD Million)
Fig. 58 Italy
Fig. 59 Italy market estimates and forecast, 2018-2030 (USD Million)
Fig. 60 Spain
Fig. 61 Spain market estimates and forecast, 2018-2030 (USD Million)
Fig. 62 Asia Pacific
Fig. 63 Asia Pacific market estimates and forecast, 2018-2030 (USD Million)
Fig. 64 Japan
Fig. 65 Japan market estimates and forecast, 2018-2030(USD Million)
Fig. 66 China
Fig. 67 China market estimates and forecast, 2018-2030 (USD Million)
Fig. 68 India
Fig. 69 India market estimates and forecast, 2018-2030 (USD Million)
Fig. 70 South Korea
Fig. 71 South Korea market estimates and forecast, 2018-2030 (USD Million)
Fig. 72 Australia
Fig. 73 Australia market estimates and forecast, 2018-2030 (USD Million)
Fig. 74 Latin America
Fig. 75 Latin America market estimates and forecast, 2018-2030 (USD Million)
Fig. 76 Brazil
Fig. 77 Brazil market estimates and forecast, 2018-2030 (USD Million)
Fig. 78 Mexico
Fig. 79 Mexico market estimates and forecast, 2018-2030 (USD Million)
Fig. 80 Argentina
Fig. 81 Argentina market estimates and forecast, 2018-2030 (USD Million)
Fig. 82 Middle East & Africa
Fig. 83 MEA market estimates and forecast, 2018-2030 (USD Million)
Fig. 84 South Africa
Fig. 85 South Africa market estimates and forecast, 2018-2030 (USD Million)
Fig. 86 Saudi Arabia
Fig. 87 Saudi Arabia market estimates and forecast, 2018-2030 (USD Million)
Fig. 88 UAE
Fig. 89 UAE market estimates and forecast, 2018-2030 (USD Million)
Fig. 90 Ansoff Matrix
Fig. 91 Market differentiators
Fig. 92 Key company market share analysis, 2021
Fig. 93 Company market position analysis
Fig. 94 Company market position analysis
Fig. 95 Competitive dashboard analysis
Fig. 96 Regional network map

Companies Mentioned

  • Abbott
  • Qiagen
  • Bio-Rad Laboratories, Inc.
  • Agilent Technologies, Inc.
  • Thermo Fisher Scientific, Inc.
  • Cytiva (GE Healthcare)
  • bioMérieux SA
  • F. Hoffmann-La Roche Ltd.
  • Fluidigm Corporation
  • STILLA
  • Microsynth AG
  • JN Medsys
  • Danaher Corporation

Methodology

Loading
LOADING...

Related Topics

Related Reports

Molecular Diagnostics Market Size, Share & Trends Analysis Report by Product (Reagents, Instruments), Technology (PCR, INAAT), Application (Oncology, Genetic Testing), Test Location, and Segment Forecasts, 2024-2030 - Product Image

Molecular Diagnostics Market Size, Share & Trends Analysis Report by Product (Reagents, Instruments), Technology (PCR, INAAT), Application (Oncology, Genetic Testing), Test Location, and Segment Forecasts, 2024-2030

  • Report
  • 270 Pages
  • Global
From
Oncology Based Molecular Diagnostics Market Size, Share & Trends Analysis Report by Type (Breast Cancer, Lung Cancer), Product (Instruments, Reagents), Technology (PCR, Sequencing), Region, and Segment Forecasts, 2023-2030 - Product Image

Oncology Based Molecular Diagnostics Market Size, Share & Trends Analysis Report by Type (Breast Cancer, Lung Cancer), Product (Instruments, Reagents), Technology (PCR, Sequencing), Region, and Segment Forecasts, 2023-2030

  • Report
  • 139 Pages
  • Global
From
PCR Technologies Market by Technique, Product Type, Application, End-user - Global Forecast 2025-2030 - Product Image

PCR Technologies Market by Technique, Product Type, Application, End-user - Global Forecast 2025-2030

  • Report
  • 183 Pages
  • Global
From
Digital PCR Market by Product Type, Technology, Application, End-User - Global Forecast 2025-2030 - Product Image

Digital PCR Market by Product Type, Technology, Application, End-User - Global Forecast 2025-2030

  • Report
  • 197 Pages
  • Global
From
PCR Technologies Market by Product (Instruments, Reagents & Consumables, Software), Application (Genotyping, Diagnostic Applications), Technique (Reverse Transcription PCR, qPCR), End-user (Hospital Labs, Diagnostic Labs) - Global Forecasts to 2030 - Product Image

PCR Technologies Market by Product (Instruments, Reagents & Consumables, Software), Application (Genotyping, Diagnostic Applications), Technique (Reverse Transcription PCR, qPCR), End-user (Hospital Labs, Diagnostic Labs) - Global Forecasts to 2030

  • Report
  • 305 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.